C57BL/6JCya-Cishem1flox/Cya
Common Name:
Cish-flox
Product ID:
S-CKO-01734
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Cish-flox
Strain ID
CKOCMP-12700-Cish-B6J-VA
Gene Name
Product ID
S-CKO-01734
Gene Alias
CIS-1; CIS1; Cis; F17; F23; SOCS
Background
C57BL/6JCya
NCBI ID
Modification
Conditional knockout
Chromosome
9
Phenotype
Document
Application
--
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Cishem1flox/Cya mice (Catalog S-CKO-01734) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000085102
NCBI RefSeq
NM_009895
Target Region
Exon 2~3
Size of Effective Region
~3.9 kb
Detailed Document
Overview of Gene Research
Cish, also known as cytokine-inducible SH2-containing protein, is a key negative regulator in multiple cytokine signaling pathways. It belongs to the suppressor of cytokine signaling (SOCS) family. Cish plays important roles in immunity, erythropoiesis, and the regulation of cell metabolism, lysosomal function, and cell activation. Genetic models, such as gene knockout (KO) and conditional knockout (CKO) mouse models, have been crucial for studying its functions [1,2,3,4,5,6,7,8,9].
In human iPSC-derived NK cells, deletion of CISH promotes metabolic reprograming, enhancing in vivo persistence and anti-tumor activity through increased IL-15-mediated JAK-STAT signaling and improved metabolic fitness [1]. In T cells from older adults, increased CISH expression impairs lysosomal function, leading to mitochondrial DNA release and inflammaging [2]. Cish knockout mice showed altered hematopoietic responses but similar outcomes to malaria infection [3]. Targeting CISH in NK cells enhances natural cytotoxicity receptor signaling, reduces NK cell exhaustion, and improves solid tumor immunity [4]. During DC development, CISH knockdown affects the expression of key molecules, DC yield, and CTL activation [5]. In alveolar macrophages, Cish deficiency leads to phenotypic changes associated with enhanced cytokine signaling [6]. In ILC2s, global or conditional CISH deficiency increases cell expansion and activation, affecting mucosal immunity [7]. In lung fibroblasts, CISH negatively regulates IL-13-induced CCL26 production related to eosinophilic inflammation in asthma [8]. In mice infected with Mycobacterium tuberculosis, CISH controls bacterial burden early after infection via innate immune mechanisms [9].
In conclusion, Cish acts as a negative regulator in multiple biological processes, including cytokine signaling, cell metabolism, and lysosomal function. KO and CKO mouse models have revealed its roles in various disease-related conditions, such as cancer, aging-related inflammation, malaria, solid tumor immunity, asthma, and tuberculosis. These findings contribute to understanding the underlying mechanisms of these diseases and may provide potential therapeutic targets.
References:
1. Zhu, Huang, Blum, Robert H, Bernareggi, Davide, Malmberg, Karl-Johan, Kaufman, Dan S. 2020. Metabolic Reprograming via Deletion of CISH in Human iPSC-Derived NK Cells Promotes In Vivo Persistence and Enhances Anti-tumor Activity. In Cell stem cell, 27, 224-237.e6. doi:10.1016/j.stem.2020.05.008. https://pubmed.ncbi.nlm.nih.gov/32531207/
2. Jin, Jun, Mu, Yunmei, Zhang, Huimin, Weyand, Cornelia M, Goronzy, Jorg J. 2023. CISH impairs lysosomal function in activated T cells resulting in mitochondrial DNA release and inflammaging. In Nature aging, 3, 600-616. doi:10.1038/s43587-023-00399-w. https://pubmed.ncbi.nlm.nih.gov/37118554/
3. Lakkavaram, Asha L, Maymand, Saeed, Naser, Wasan, Ward, Alister C, de Koning-Ward, Tania F. 2023. Cish knockout mice exhibit similar outcomes to malaria infection despite altered hematopoietic responses. In Frontiers in microbiology, 14, 1288876. doi:10.3389/fmicb.2023.1288876. https://pubmed.ncbi.nlm.nih.gov/38029163/
4. Bernard, Pierre-Louis, Delconte, Rebecca, Pastor, Sonia, Nunes, Jacques, Guittard, Geoffrey. . Targeting CISH enhances natural cytotoxicity receptor signaling and reduces NK cell exhaustion to improve solid tumor immunity. In Journal for immunotherapy of cancer, 10, . doi:10.1136/jitc-2021-004244. https://pubmed.ncbi.nlm.nih.gov/35589278/
5. Miah, Mohammad Alam, Yoon, Cheol-Hee, Kim, Joonoh, Seong, Young-Rim, Bae, Yong-Soo. 2011. CISH is induced during DC development and regulates DC-mediated CTL activation. In European journal of immunology, 42, 58-68. doi:10.1002/eji.201141846. https://pubmed.ncbi.nlm.nih.gov/22002016/
6. Shoger, Karsen E, Cheemalavagu, Neha, Cao, Yuqi M, Singh, Harinder, Gottschalk, Rachel A. 2021. CISH attenuates homeostatic cytokine signaling to promote lung-specific macrophage programming and function. In Science signaling, 14, eabe5137. doi:10.1126/scisignal.abe5137. https://pubmed.ncbi.nlm.nih.gov/34516753/
7. Kotas, Maya E, Mroz, Nicholas M, Koga, Satoshi, Schneider, Christoph, Locksley, Richard M. 2021. CISH constrains the tuft-ILC2 circuit to set epithelial and immune tone. In Mucosal immunology, 14, 1295-1305. doi:10.1038/s41385-021-00430-6. https://pubmed.ncbi.nlm.nih.gov/34290377/
8. Takeshima, Hideyuki, Horie, Masafumi, Mikami, Yu, Nagase, Takahide, Yamauchi, Yasuhiro. 2018. CISH is a negative regulator of IL-13-induced CCL26 production in lung fibroblasts. In Allergology international : official journal of the Japanese Society of Allergology, 68, 101-109. doi:10.1016/j.alit.2018.08.005. https://pubmed.ncbi.nlm.nih.gov/30197185/
9. Carow, Berit, Gao, Yu, Terán, Graciela, Yoshimura, Akihiko, Rottenberg, Martin E. 2017. CISH controls bacterial burden early after infection with Mycobacterium tuberculosis in mice. In Tuberculosis (Edinburgh, Scotland), 107, 175-180. doi:10.1016/j.tube.2017.09.007. https://pubmed.ncbi.nlm.nih.gov/29050767/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen